Investors

Cannabis Through Art and Science

Download/Sign up

for Investor Presentation Updates

Adastra Labs & Chemia Analytics

Facility Tour

A look inside one of Canada's largest extraction facilities

At Adastra Labs, our approach is and always has been to develop our processes with efficiency, and end-product quality in mind. Our 13,000 sq ft facility was purpose built, with input from experienced scientists, who have formal education and a passion for the plant. One of our first hires, Donald Dinsmore, Adastra Labs’ QAP, walks you through our facility and gives you a behind-the-scenes look at our Supercritical CO2 process because alongside quality, we believe transparency is key.

Current Market

Stock Symbol: XTRX on CSE

Press Releases

Adastra Labs CEO Andy Hale Proactive Interview Steve Darling

Adastra CEO Andy Hale interviewed by Proactive Investors’ Steve Darling

Our CEO Andy had a recent chat with Proactive Investor’s Steve Darling to share what sets Adastra ahead of the competition and how COVID-19 didn’t slow us down. He talks about our state-of-the-art facility, the advantage of in-house testing through Chemia Analytics, partnership with Cannmart, new permits, and our expansion plan for cannabis hydrocarbon extraction.

Read More »

Adastra Signs LOI to Acquire Iconic Legacy Market Phyto Extractions Brands

LANGLEY, BC / ACCESSWIRE / September 18, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX)  (FRANKFURT: D2EP) (“Adastra”) a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce it has signed a Letter of Intent (“LOI”) for the acquisition of Phyto Extractions Brands (“Phyto Extractions”). Adastra entered into an LOI on September 16,

Read More »

Adastra Begins Cannabis Hydrocarbon Extraction Expansion Plan

LANGLEY, BC / ACCESSWIRE / September 16, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX)  (FRANKFURT: D2EP) (“Adastra”) a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the commencement of its hydrocarbon extraction expansion plan. “At Adastra we are very excited as we begin our hydrocarbon extraction expansion plan.  This is our

Read More »

Adastra to Partner with JOYN for Disruptive Cannabis Powder Tech

LANGLEY, BC / ACCESSWIRE / August 25, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX)  (FRANKFURT: D2EP) (“Adastra”) a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce a Letter of Intent (LOI) to enter into a partnership with JOYN Botanicals Ltd. (“JOYN”) for the exclusive Canadian use of its patent-pending SoluCann cannabis

Read More »

Adastra to Exclusively Produce Cessa CBD Concentrate Products

LANGLEY, BC / ACCESSWIRE / August 20, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce it has been engaged by a cannabis brands company for the exclusive production of a new line of products branded under the label Cessa CBD (“Cessa”).

Read More »

Adastra Announces Supply Agreement with Pure Sunfarms

LANGLEY, BC /  August 17, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce a cannabis supply agreement with Pure Sunfarms Corp. (“Pure Sunfarms”). “We are pleased to finalize this cannabis biomass agreement with Pure Sunfarms. With a

Read More »

Public Filings

Contact Us

Have a question? Want more information? Looking for a partner to deliver the exceptional service you need for your future business? If you're passionate about cannabis, we'd love to hear from you.

F: 844-874-9893
E: info@adastralabs.ca

5451 275th Street 
Langley, BC, Canada, V4W 3X8

Scroll to Top